GSDMD and neoplasm: Here the authors report a toolbox of gasdermin D variants for induction of pyroptosis, showing that, when combined with intratumoral expression of cytokines (IL-1β, IL-12, or IL-18), anti-tumor immune responses in preclinical models are enhanced.